Shuttle secures more than $5M at close of public offering

Shuttle Pharmaceuticals Holdings has closed a previously announced underwritten public common stock offering, with aggregate gross proceeds of approximately $5.8 million.

The Gaithersburg, MD-based specialty pharmaceutical company offered 19.1 million shares of its common stock at a public offering price of 30¢ per share. WestPark Capital acted as the sole book-runner in connection with the offering.

Net proceeds will fund a phase II clinical trial for Shuttle's lead product candidate, marketing and advertising services, and working capital and general corporate purposes, according to the firm.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.